<?xml version="1.0" encoding="UTF-8"?>
<p id="p0085">Nsp12 or RdRp is the main conserved protein present in coronavirus which is responsible for viral replication and transcription. It is a complex machinery, where Nsp12 binds with nsp7 and nsp8 (cofactors) to produce viral genomic RNA [
 <xref rid="bib66" ref-type="bibr">66</xref>]. SARS-CoV shares the same structure of Nsp12 with the SARS-CoV-2. It was observed that Nsp12 was the potential drug target with much safer profile and less toxicity for SARS-CoV and MERS-CoV [
 <xref rid="bib52" ref-type="bibr">52</xref>]. Currently, remdesivir (antiviral drug) that targets RdRp activity is under clinical trial and also been used in severely ill-terminal COVID19 patients [
 <xref rid="bib67" ref-type="bibr">67</xref>]. Docking-based screening studies have found some natural compounds targeting RdRp including nympholide A, viniferin and theaflavin [
 <xref rid="bib55" ref-type="bibr">55</xref>,
 <xref rid="bib68" ref-type="bibr">68</xref>].
</p>
